BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 37655344)

  • 1. Salivary and fecal microbiota: potential new biomarkers for early screening of colorectal polyps.
    Zhang L; Feng Z; Li Y; Lv C; Li C; Hu Y; Fu M; Song L
    Front Microbiol; 2023; 14():1182346. PubMed ID: 37655344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.
    Rezasoltani S; Sharafkhah M; Asadzadeh Aghdaei H; Nazemalhosseini Mojarad E; Dabiri H; Akhavan Sepahi A; Modarressi MH; Feizabadi MM; Zali MR
    J Microbiol Methods; 2018 Dec; 155():82-88. PubMed ID: 30439465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota signatures in tissues of the colorectal polyp and normal colorectal mucosa, and faeces.
    Zhong X; Wang Y; Xu J; Cao H; Zhang F; Wang X
    Front Cell Infect Microbiol; 2022; 12():1054808. PubMed ID: 36704106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Non-Invasive Prediction and New Biomarkers of Oral and Fecal Microbiota in Patients With Gastric and Colorectal Cancer.
    Zhang C; Hu A; Li J; Zhang F; Zhong P; Li Y; Li Y
    Front Cell Infect Microbiol; 2022; 12():830684. PubMed ID: 35663463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
    Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
    Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer.
    Yao Q; Tang M; Zeng L; Chu Z; Sheng H; Zhang Y; Zhou Y; Zhang H; Jiang H; Ye M
    BMC Microbiol; 2021 May; 21(1):156. PubMed ID: 34044781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of the presence of
    Chen X; Xian B; Wei J; Chen Y; Yang D; Lai X; Liu L; Wu Y; Lin X; Deng Y; Zhang H; Liu W; Qiao G; Li Z
    Front Cell Infect Microbiol; 2022; 12():997333. PubMed ID: 36310858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing.
    Liu W; Zhang R; Shu R; Yu J; Li H; Long H; Jin S; Li S; Hu Q; Yao F; Zhou C; Huang Q; Hu X; Chen M; Hu W; Wang Q; Fang S; Wu Q
    Biomed Res Int; 2020; 2020():7828392. PubMed ID: 32083132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal Cancer Stage-Specific Fecal Bacterial Community Fingerprinting of the Taiwanese Population and Underpinning of Potential Taxonomic Biomarkers.
    Fang CY; Chen JS; Hsu BM; Hussain B; Rathod J; Lee KH
    Microorganisms; 2021 Jul; 9(8):. PubMed ID: 34442626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using 16S rDNA and metagenomic sequencing technology to analyze the fecal microbiome of children with avoidant/restrictive food intake disorder.
    Ye Q; Sun S; Deng J; Chen X; Zhang J; Lin S; Du H; Gao J; Zou X; Lin X; Cai Y; Lu Z
    Sci Rep; 2023 Nov; 13(1):20253. PubMed ID: 37985845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
    Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
    Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas.
    Lo CH; Wu DC; Jao SW; Wu CC; Lin CY; Chuang CH; Lin YB; Chen CH; Chen YT; Chen JH; Hsiao KH; Chen YJ; Chen YT; Wang JY; Li LH
    J Biomed Sci; 2022 Oct; 29(1):88. PubMed ID: 36303164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between fecal microbiota and different types of colorectal polyp as precursors of colorectal cancer.
    Rezasoltani S; Asadzadeh Aghdaei H; Dabiri H; Akhavan Sepahi A; Modarressi MH; Nazemalhosseini Mojarad E
    Microb Pathog; 2018 Nov; 124():244-249. PubMed ID: 30142468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.
    Avuthu N; Guda C
    Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
    Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of Changes in the Fecal Microbiota Associated with Colonic Adenomatous Polyps Using a Long-Read Sequencing Platform.
    Wei PL; Hung CS; Kao YW; Lin YC; Lee CY; Chang TH; Shia BC; Lin JC
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33233735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
    Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
    Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF
    Trivieri N; Pracella R; Cariglia MG; Panebianco C; Parrella P; Visioli A; Giani F; Soriano AA; Barile C; Canistro G; Latiano TP; Dimitri L; Bazzocchi F; Cassano D; Vescovi AL; Pazienza V; Binda E
    J Exp Clin Cancer Res; 2020 Dec; 39(1):285. PubMed ID: 33317591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saliva‑microbiome‑derived signatures: expected to become a potential biomarker for pulmonary nodules (MCEPN-1).
    Ren Y; Ma Q; Zeng X; Huang C; Tan S; Fu X; Zheng C; You F; Li X
    BMC Microbiol; 2024 Apr; 24(1):132. PubMed ID: 38643115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy.
    Russo E; Gloria LD; Nannini G; Meoni G; Niccolai E; Ringressi MN; Baldi S; Fani R; Tenori L; Taddei A; Ramazzotti M; Amedei A
    Neoplasia; 2023 Jun; 40():100901. PubMed ID: 37058886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.